Abstract |
The Securinega alkaloids are a class of natural products isolated from plants of the Euphorbiaceae family. L- securinine induces apoptosis in the human promyelocytic leukemia cell line HL-60 indicating its potential as an efficient natural antitumor drug with low toxicity. The aim of the present study was to investigate the apoptotic effects of L- securinine on HL-60 cells and to explore its potential underlying molecular mechanism(s) as an antitumor agent. HL-60 cells were cultured with L- securinine. The proliferation and changes in cell morphology were evaluated by cell counting Kit-8 (CCK-8) assay and electron microscopy, respectively. Induction of apoptosis and cell cycle progression were investigated by flow cytometry. The PI3K/AKT/mTOR pathway gene expression was measured by quantitative PCR (qPCR). L- securinine decreased the viability of HL-60 cells in a dose- and time-dependent manner, with IC50 values at 24, 48 and 72 h post-treatment of 47.88, 23.85 and 18.87 µmol/l, respectively. Numerous apoptotic bodies were observed in the HL-60 cells treated with 25 µmol/l L- securinine for 48 h. L- securinine at 12.5, 25 and 50 µmol/l increased the rate of apoptosis in HL-60 cells, and G1/S phase progression was retarded. Furthermore, L- securinine induced downregulation of PI3K, AKT and mTOR gene expression and upregulation of PTEN gene expression in a dose-dependent manner. In conclusion, L- securinine induces apoptosis and inhibition of cell cycle progression in HL-60 cells by modulation of the PI3K/AKT/mTOR pathway gene expression. These observations indicate the potential of L- securinine as an antitumor agent.
|
Authors | Shuwen Han, Gang Zhang, Maidong Li, Dongyun Chen, Ying Wang, Wencai Ye, Zhaoning Ji |
Journal | Oncology reports
(Oncol Rep)
Vol. 31
Issue 5
Pg. 2245-51
(May 2014)
ISSN: 1791-2431 [Electronic] Greece |
PMID | 24676995
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents, Phytogenic
- Azepines
- Heterocyclic Compounds, Bridged-Ring
- Lactones
- Piperidines
- MTOR protein, human
- Proto-Oncogene Proteins c-akt
- TOR Serine-Threonine Kinases
- PTEN Phosphohydrolase
- PTEN protein, human
- securinine
|
Topics |
- Antineoplastic Agents, Phytogenic
(pharmacology)
- Apoptosis
(drug effects)
- Azepines
(pharmacology)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Gene Expression
- HL-60 Cells
- Heterocyclic Compounds, Bridged-Ring
(pharmacology)
- Humans
- Lactones
(pharmacology)
- Leukemia, Promyelocytic, Acute
(drug therapy)
- MAP Kinase Signaling System
(genetics)
- PTEN Phosphohydrolase
(biosynthesis)
- Phosphatidylinositol 3-Kinases
(biosynthesis, genetics)
- Piperidines
(pharmacology)
- Proto-Oncogene Proteins c-akt
(biosynthesis, genetics)
- S Phase Cell Cycle Checkpoints
(drug effects)
- TOR Serine-Threonine Kinases
(biosynthesis, genetics)
|